Pathobiology of antineoplastic therapy in undifferentiated thyroid cancer.
Ain
Kenneth B
KB
Thyroid Oncology Program, Division of Hematology & Oncology, Department of Internal Medicine, University of Kentucky, Lexington, KY 40536, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002454:Cell Differentiation; D005544:Forecasting; D006801:Humans; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000503:physiopathology
D000970:Antineoplastic Agents